LNQ-23066-06875
3 vaccinations
3 coded responses
34 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 294 / SC
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-17
Dose 1 — Pfizer-BioNTech
-
2020-12-18
Registered in v-safe
-
2020-12-18
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Fatigue or tirednessAdult check-in
-
2020-12-19
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Fever · Fatigue or tirednessFree text: Swollen axillary lymph nodes on same side as injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2020-12-21
- 2020-12-26
- 2020-12-31
-
2021-01-05
Dose 2 — Pfizer-BioNTech
-
2021-01-06
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-06
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities2 call case(s)
-
2021-01-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-09
- 2021-01-11
- 2021-01-12
- 2021-01-19
- 2021-01-26
- 2021-02-02
-
2021-02-09
Survey response — day 35, dose 2MedDRA: Fatigue, Headache, Post-acute COVID-19 syndrome — Feeling: FairFree text: Headache, fatigue (long covid symptoms, not necessarily related to vaccine)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-16
- 2021-04-06
- 2021-07-06
-
2021-09-28
Dose 3 — Pfizer-BioNTech
- 2021-09-28
-
2021-09-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-12
- 2021-10-19
- 2021-10-26
- 2021-11-02
- 2021-11-09
- 2021-12-28
- 2022-03-29
-
2022-09-28
Survey response — 12 months, dose 3MedDRA: Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Diastolic hypertension, dysautonomiaMedDRA releases: 2024-11 · check-in free text available
-
2022-09-28
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-09-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-05 | Pfizer-BioNTech | |
| 3 | 2021-09-28 | Pfizer-BioNTech | No |
Call center
3 call center cases
1 unsuccessful · 2 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Swollen axillary lymph nodes on same side as injection
Release 3 — day 35, dose 2
Symptoms: Headache, fatigue (long covid symptoms, not necessarily related to vaccine)
Release 12 — 12 months, dose 3
Symptoms: Diastolic hypertension, dysautonomia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Post-acute COVID-19 syndrome | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release